| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |